HNSCC
Nivolumab Improves Survival in Refractory HNSCC
Copenhagen, Denmark—Patients with platinum-refractory, recurrent head and neck squamous cell carcinoma ...
DECEMBER 23, 2016
Pinning Down Stem Cell Biomarkers May
Pave
Way for Targeted Therapies for HNSCC
A more-sophisticated understanding of stem cells in head and neck squamous cell carcinoma has the potential to help ...
APRIL 25, 2016
HNSCC Stem Cell Signaling
Implicated
As “Key” to Tumor Response to DNA Damage
Not only is stem cell signaling in head and neck squamous cell carcinoma (HNSCC) an important component of the ...
APRIL 25, 2016
Load more